Joel F. Farley - College of Pharmacy, University of Minnesota

基本信息

浏览量：32

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 213 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

COMPARATIVE EFFECTIVENESS OF GLUCAGON-LIKE PEPTIDE 1 AGONISTS VS DIPEPTIDYL PEPTIDASE 4 INHIBITORS ON LIVER OUTCOMES IN PATIENTS WITH TYPE 2 DIABETES AND METABOLIC DYSFUNCTION-ASSOCIATED FATTY LIVER DISEASE

T. H. Shen,J. F. Farley

VALUE IN HEALTHno. 6 (2024): S24-S24

引用0浏览0引用

HPR127 Examine the Use of Real-World Evidence to Support FDA Decision-Making for New Drug Applications and Biologics License Applications from 2021 to 2022

CH Cheng,JF Farley

Value in Healthno. 6 (2024): S216

引用0浏览0引用

CO41 Comparative Effectiveness of Glucagon-like Peptide 1 Agonists Vs Dipeptidyl Peptidase 4 Inhibitors on Liver Outcomes in Patients with Type 2 Diabetes and Metabolic Dysfunction-Associated Fatty Liver Disease

T.H. Shen,J.F. Farley

Value in Healthno. 6 (2024): S24

引用0浏览0引用

Comprehensive Medication Review Completion Rates and Disparities after Medicare Star Rating Measure

Anna Hung,Lauren Wilson,Valerie A. Smith,Juliessa M. Pavon,Caroline E. Sloan,Susan N. Hastings,Joel Farley,Matthew L. Maciejewski

JAMA HEALTH FORUMno. 5 (2024)

引用0浏览0WOS引用

Impact of Initiating Oral Anticancer Agents for Leukemia on Adherence to Medications for Multiple Chronic Conditions

Justin Gatwood,Ankur Dashputre,Abhijeet Rajpurohit,Katie Gatwood,Emily Mackler,Leah Wallace,Karen Farris,Amna Rizvi-Toner,Joel Farley

JOURNAL OF ONCOLOGY PHARMACY PRACTICE（2024）

引用0浏览0WOS引用

EXAMINE THE USE OF REAL-WORLD EVIDENCE TO SUPPORT FDA DECISION-MAKING FOR NEW DRUG APPLICATIONS AND BIOLOGICS LICENSE APPLICATIONS FROM 2021 TO 2022

C. H. Cheng,J. F. Farley

VALUE IN HEALTHno. 6 (2024): S216-S216

引用0浏览0引用

Integrating Clinical Pharmacists into Transitions of Care: A Qualitative Study of Barriers and Facilitators among Federally Qualified Health Centers

Ben C. D. Weideman,Katie M. White,Joel F. Farley,Lindsay A. Sorge, Swetha Pradeep,Athena Cannon, Kim Tran,Deborah L. Pestka

JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACYno. 5 (2024): 434-442

引用0浏览0引用

Managing Medications for Patients with Cancer and Chronic Conditions: It's Time for Collaboration Between Primary Care and Oncology Pharmacists

Arielle Davidson, Mohamad Ismail,Justin Gatwood,Joel Farley,Emily Mackler,Amy Thompson,Karen Farris

Journal of Oncology Pharmacy Practice（2024）

引用0浏览0WOS引用

Sodium-glucose Co-Transporter-2 Inhibitors Versus Dipeptidyl Peptidase-4 Inhibitors on Major Liver Outcomes in Metabolic Dysfunction-Associated Steatotic Liver Disease

Tsung-Hua Shen, Elizabeth S. Aby,David Vock,Joel F. Farley

DIABETES OBESITY & METABOLISMno. 11 (2024): 5116-5125

引用0浏览0WOS引用

Potential Benefits of Incorporating Social Determinants of Health Screening on Comprehensive Medication Management Effectiveness

Joel F Farley, Swetha Pradeep

Journal of managed care & specialty pharmacyno. 11 (2024): 1217-1224

引用0浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn